Evommune, Inc. (EVMN) Operating margin 2024–2025
Evommune, Inc. (EVMN) operating margin by fiscal year — reported operating income divided by reported revenue.
-623.6%FY2025 · since FY2024: -1000.2% → -623.6%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -623.6% | +376.6 pp |
| FY2024 | -1000.2% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More EVMN financial trends
EVMN RevenueEVMN Net incomeEVMN Net marginEVMN Gross profitEVMN Gross marginEVMN Operating incomeEVMN Operating cash flowEVMN Free cash flowEVMN Capital expendituresEVMN Return on equityEVMN Stock buybacksEVMN Dividends paidEVMN Total assetsEVMN Total liabilitiesEVMN Shareholders’ equityEVMN overview →